Literature DB >> 9798961

RBE-LET relationships for cell inactivation and mutation induced by low energy protons in V79 cells: further results at the LNL facility.

M Belli1, F Cera, R Cherubini, M Dalla Vecchia, A M Haque, F Ianzini, G Moschini, O Sapora, G Simone, M A Tabocchini, P Tiveron.   

Abstract

PURPOSE: RBE-LET relationships for cell inactivation and hprt mutation in V79 cells have been studied with mono-energetic low-energy proton beams at the radiobiological facility of the INFN-Laboratori Nazionali di Legnaro (LNL), Padova, Italy.
MATERIALS AND METHODS: V79 cells were irradiated in mono-layer on mylar coated stainless steel petri dishes, in air. Inactivation data were obtained at 7.7, 34.6 and 37.8 keV/microm and hprt mutation was studied at 7 7 and 37.8 keV/microm. Additional data were also collected for both the end points with the proton LET already considered in our previous publications, namely 11.0, 20.0 and 30.5 keV/microm.
RESULTS: A maximum in the RBE-LET relationship for cell inactivation was found at around 31 keV/microm, while the RBE for mutation induction increased continuously with LET.
CONCLUSIONS: The proton RBE-LET relationship for cell inactivation is shifted to lower LET values compared with that for heavier ions. For mutation induction, protons of LET equal to 7.7keV/microm gave an RBE value comparable with that obtained by helium ions of about 20 keV/microm. Mutagenicity and lethality caused by protons at low doses in the LET range 7.7-31 keV/microm were proportional, while the data at 37.8 keV/microm suggest that this may not hold at higher LET values.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9798961     DOI: 10.1080/095530098141375

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  19 in total

1.  The potential impact of relative biological effectiveness uncertainty on charged particle treatment prescriptions.

Authors:  B Jones; T S A Underwood; R G Dale
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  Phenomenological explanation of cell inactivation cross section in terms of direct and indirect action.

Authors:  Faika A Azooz; Suaad A Meerkhan
Journal:  Sultan Qaboos Univ Med J       Date:  2010-04-17

3.  Calculation of the inactivation cross section of v79 cells by protons in radiotherapy.

Authors:  Faika A Azooz; Thamer J Alkhalidy
Journal:  Sultan Qaboos Univ Med J       Date:  2007-12

4.  Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning.

Authors:  Clemens Grassberger; Alexei Trofimov; Anthony Lomax; Harald Paganetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-14       Impact factor: 7.038

5.  Modeling radiation-induced cell death: role of different levels of DNA damage clustering.

Authors:  M P Carante; S Altieri; S Bortolussi; I Postuma; N Protti; F Ballarini
Journal:  Radiat Environ Biophys       Date:  2015-05-09       Impact factor: 1.925

6.  From DNA radiation damage to cell death: theoretical approaches.

Authors:  Francesca Ballarini
Journal:  J Nucleic Acids       Date:  2010-10-05

7.  Is the risk for secondary cancers after proton therapy enhanced distal to the Planning Target Volume? A two-case report with possible explanations.

Authors:  Uwe Schneider; Anthony Lomax; Beat Hauser; Barbara Kaser-Hotz
Journal:  Radiat Environ Biophys       Date:  2006-02-07       Impact factor: 1.925

8.  Low energy proton beam induces tumor cell apoptosis through reactive oxygen species and activation of caspases.

Authors:  Kheun Byeol Lee; Jong Soo Lee; Jeen Woo Park; Tae Lin Huh; You Mie Lee
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

9.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.

Authors:  Aimee L McNamara; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-10-13       Impact factor: 3.609

10.  Modelling recurrence and second cancer risks induced by proton therapy.

Authors:  V S K Manem; A Dhawan
Journal:  Math Med Biol       Date:  2018-09-11       Impact factor: 1.854

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.